EVALUATION OF BIOMARKERS OF ATOPIC DERMATITIS IN PEDIATRIC PATIENTS WHOSE DISEASE IS NOT ADEQUATELY CONTROLLED WITH TOPICAL PRESCRIPTION THERAPIES OR WHEN THOSE THERAPIES ARE NOT MEDICALLY ADVISABLE
Recruiting
- Conditions
- atopic dermatitiseczema10014982
- Registration Number
- NL-OMON48261
- Lead Sponsor
- Sanofi-aventis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
1. Participation in the OBS15333 pediatric AD registry
2. Signed informed consent by the parent/legally acceptable
representative and assent by the participant appropriate to the
participant*s age.
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Biomarkers including genetic and protein data.</p><br>
- Secondary Outcome Measures
Name Time Method <p>not applicable</p><br>